147 related articles for article (PubMed ID: 12120752)
1. Studies for the emetic mechanisms of ipecac syrup (TJN-119) and its active components in ferrets: involvement of 5-hydroxytryptamine receptors.
Hasegawa M; Sasaki T; Sadakane K; Tabuchi M; Takeda Y; Kimura M; Fujii Y
Jpn J Pharmacol; 2002 Jun; 89(2):113-9. PubMed ID: 12120752
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological aspects of ipecac syrup (TJN-119)-induced emesis in ferrets.
Endo T; Nemoto M; Ogawa T; Tamakai H; Hamaue N; Hirafuji M; Takeda Y; Hasegawa M; Fugii Y; Minami M
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):187-200. PubMed ID: 11913711
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of the ipecac alkaloids cephaeline and emetine from ipecac syrup in rats.
Asano T; Watanabe J; Sadakane C; Ishihara K; Hirakura K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Fujii Y; Yamashita M
Eur J Drug Metab Pharmacokinet; 2002; 27(1):29-35. PubMed ID: 11996324
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats.
Asano T; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Kuroiwa Y; Fujii Y; Yamashita M; Kuramochi T; Tomisawa H; Tateishi M
Eur J Drug Metab Pharmacokinet; 2002; 27(1):17-27. PubMed ID: 11996323
[TBL] [Abstract][Full Text] [Related]
5. Single dose pharmacokinetics of syrup of ipecac.
Scharman EJ; Hutzler JM; Rosencrance JG; Tracy TS
Ther Drug Monit; 2000 Oct; 22(5):566-73. PubMed ID: 11034262
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of emetic and United State pharmacopoeia ipecac syrup in prevention of drug absorption.
Teshima D; Suzuki A; Otsubo K; Higuchi S; Aoyama T; Shimozono Y; Saita M; Noda K
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2242-5. PubMed ID: 1980639
[TBL] [Abstract][Full Text] [Related]
7. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
Yoshikawa T; Yoshida N; Oka M
Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
[TBL] [Abstract][Full Text] [Related]
8. Toxicology of ipecac: a review.
Manno BR; Manno JE
Clin Toxicol; 1977; 10(2):221-42. PubMed ID: 15766
[TBL] [Abstract][Full Text] [Related]
9. 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin.
Rudd JA; Ngan MP; Wai MK
Eur J Pharmacol; 1998 Jul; 352(2-3):143-9. PubMed ID: 9716348
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of ipecac alkaloids cephaeline and emetine by human hepatic microsomal cytochrome P450s, and their inhibitory effects on P450 enzyme activities.
Asano T; Kushida H; Sadakane C; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T
Biol Pharm Bull; 2001 Jun; 24(6):678-82. PubMed ID: 11411558
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the antiemetic effects of a 5-HT1A agonist, LY228729, and 5-HT3 antagonists in the pigeon.
Wolff MC; Leander JD
Pharmacol Biochem Behav; 1995 Nov; 52(3):571-5. PubMed ID: 8545476
[TBL] [Abstract][Full Text] [Related]
12. Effect of zatosetron on ipecac-induced emesis in dogs and healthy men.
Schwartz SM; Goldberg MJ; Gidda JS; Cerimele BJ
J Clin Pharmacol; 1994 Mar; 34(3):250-4. PubMed ID: 7517409
[TBL] [Abstract][Full Text] [Related]
13. Three new O-methyltransferases are sufficient for all O-methylation reactions of ipecac alkaloid biosynthesis in root culture of Psychotria ipecacuanha.
Nomura T; Kutchan TM
J Biol Chem; 2010 Mar; 285(10):7722-38. PubMed ID: 20061395
[TBL] [Abstract][Full Text] [Related]
14. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
15. Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
Cooper M; Sologuren A; Valiente R; Smith J
Arzneimittelforschung; 2002; 52(9):689-94. PubMed ID: 12404884
[TBL] [Abstract][Full Text] [Related]
16. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
Yamano M; Ito H; Kamato T; Miyata K
Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
[TBL] [Abstract][Full Text] [Related]
18. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
20. Absorption of ipecac alkaloids in emergency patients.
Moran DM; Crouch DJ; Finkle BS
Ann Emerg Med; 1984 Dec; 13(12):1100-2. PubMed ID: 6150666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
